About MSBiotec
MSBiotec is a company based in Wamego (United States) founded in 2005. MSBiotec has raised $60.99 million across 2 funding rounds from investors including Paine Schwartz Partners. MSBiotec offers products and services including Multimin 90 and Lactipro. MSBiotec operates in a competitive market with competitors including Biomin, Native Microbials, Menon, Leiber and Wobble Base Bioresearch, among others.
- Headquarter Wamego, United States
-
Sectors
Agriculture
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$60.99 M (USD)
in 2 rounds
-
Latest Funding Round
$59.08 M (USD), Series B
Oct 03, 2018
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of MSBiotec
MSBiotec offers a comprehensive portfolio of products and services, including Multimin 90 and Lactipro.
Provides essential minerals to support cattle health and reproduction.
Enhances lactic acid utilization in cattle for better digestion.
People of MSBiotec
Unlock access to complete
Funding Insights of MSBiotec
MSBiotec has successfully raised a total of $60.99M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $59.08 million completed in October 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in MSBiotec
MSBiotec has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Paine Schwartz Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investment firm focused on food and agribusiness sectors
|
Locked | Locked | Locked |
Investor details for MSBiotec
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by MSBiotec
Investment portfolio details for MSBiotec
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - MSBiotec
Detailed financials for MSBiotec
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Msbiotec Comparisons
Peer comparison for MSBiotec
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of MSBiotec
MSBiotec operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biomin, Native Microbials, Menon, Leiber and Wobble Base Bioresearch, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Feed additives and nutritional supplements for livestock are developed.
|
|
| Locked | Locked | Locked |
Microbial solutions for animals are developed using proprietary technologies.
|
|
| Locked | Locked | Locked |
Conversion of agriculture byproducts into animal feedstock and development of biosensors for pathogen detection
|
|
| Locked | Locked | Locked |
Manufacturer of value-added products from spent brewer's yeast
|
|
| Locked | Locked | Locked |
Developer of biological product for animal gut infection mitigation and human molecular biology
|
Detailed competitors of MSBiotec
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Msbiotec
Complete news archive for MSBiotec
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MSBiotec
MSBiotec was founded in 2005 and raised its 1st funding round 7 years after it was founded.
MSBiotec is headquartered in Wamego, United States. It is registered at Wamego, Kansas, United States.
Leander Walt is the current CEO of MSBiotec.
MSBiotec is a funded company, having raised a total of $60.99M across 2 funding rounds to date.
Manufacturer and distributor of biological farm inputs for cattle. It offers a natural feed supplement for ruminant animals. The company claims to produce the product using a robust strain of a lactic acid-utilizing bacteria which acts as an oral drench for cattle at the time of transition from low- to high-concentrate diets.
MSBiotec's top competitors include Biomin, Native Microbials and Leiber.
MSBiotec offers Multimin 90 and Lactipro.
MSBiotec has 1 investor. Key investors include Paine Schwartz Partners.